Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Hemosol Inc., Fresenius A.G. deal

HML (Toronto) and Fresenius (Oberursel, Germany) formalized a previously announced strategic alliance to develop Hemolink, HML's red

Read the full 179 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE